| UniProt ID | TOB2_HUMAN | |
|---|---|---|
| UniProt AC | Q14106 | |
| Protein Name | Protein Tob2 | |
| Gene Name | TOB2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 344 | |
| Subcellular Localization | Cytoplasm. | |
| Protein Description | Anti-proliferative protein inhibits cell cycle progression from the G0/G1 to S phases.. | |
| Protein Sequence | MQLEIKVALNFIISYLYNKLPRRRADLFGEELERLLKKKYEGHWYPEKPLKGSGFRCVHIGEMVDPVVELAAKRSGLAVEDVRANVPEELSVWIDPFEVSYQIGEKGAVKVLYLDDSEGCGAPELDKEIKSSFNPDAQVFVPIGSQDSSLSNSPSPSFGQSPSPTFIPRSAQPITFTTASFAATKFGSTKMKKGGGAASGGGVASSGAGGQQPPQQPRMARSPTNSLLKHKSLSLSMHSLNFITANPAPQSQLSPNAKEFVYNGGGSPSLFFDAADGQGSGTPGPFGGSGAGTCNSSSFDMAQVFGGGANSLFLEKTPFVEGLSYNLNTMQYPSQQFQPVVLAN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 40 | Phosphorylation | ERLLKKKYEGHWYPE HHHHHHHHCCCCCCC | 35.70 | 20090780 | |
| 110 | Ubiquitination | IGEKGAVKVLYLDDS ECCCCCEEEEEEECC | 26.45 | 29967540 | |
| 127 | Ubiquitination | CGAPELDKEIKSSFN CCCHHHHHHHHHCCC | 74.16 | 29967540 | |
| 153 | Phosphorylation | QDSSLSNSPSPSFGQ CCCCCCCCCCCCCCC | 24.31 | 22252318 | |
| 155 | Phosphorylation | SSLSNSPSPSFGQSP CCCCCCCCCCCCCCC | 32.75 | 22252318 | |
| 157 | Phosphorylation | LSNSPSPSFGQSPSP CCCCCCCCCCCCCCC | 46.47 | 29802988 | |
| 163 | Phosphorylation | PSFGQSPSPTFIPRS CCCCCCCCCCCCCCC | 41.65 | 22252318 | |
| 170 | O-linked_Glycosylation | SPTFIPRSAQPITFT CCCCCCCCCCCEEEE | 26.38 | 31492838 | |
| 193 | Acetylation | FGSTKMKKGGGAASG CCCCCCEECCCCCCC | 60.33 | 11411281 | |
| 193 | Ubiquitination | FGSTKMKKGGGAASG CCCCCCEECCCCCCC | 60.33 | 29967540 | |
| 199 | Phosphorylation | KKGGGAASGGGVASS EECCCCCCCCCCCCC | 37.12 | 26074081 | |
| 205 | Phosphorylation | ASGGGVASSGAGGQQ CCCCCCCCCCCCCCC | 27.22 | 26074081 | |
| 206 | Phosphorylation | SGGGVASSGAGGQQP CCCCCCCCCCCCCCC | 23.95 | 26074081 | |
| 222 | Phosphorylation | QQPRMARSPTNSLLK CCCCCCCCCCHHHHH | 26.91 | 30266825 | |
| 224 | Phosphorylation | PRMARSPTNSLLKHK CCCCCCCCHHHHHHH | 38.39 | 30266825 | |
| 226 | Phosphorylation | MARSPTNSLLKHKSL CCCCCCHHHHHHHHE | 37.24 | 23403867 | |
| 232 | Phosphorylation | NSLLKHKSLSLSMHS HHHHHHHHEEEEECC | 23.94 | 27251275 | |
| 234 | Phosphorylation | LLKHKSLSLSMHSLN HHHHHHEEEEECCCE | 26.03 | 19690332 | |
| 236 | Phosphorylation | KHKSLSLSMHSLNFI HHHHEEEEECCCEEE | 15.86 | 27251275 | |
| 239 | Phosphorylation | SLSLSMHSLNFITAN HEEEEECCCEEEECC | 19.16 | 27251275 | |
| 244 | Phosphorylation | MHSLNFITANPAPQS ECCCEEEECCCCCHH | 19.08 | 27251275 | |
| 251 | Phosphorylation | TANPAPQSQLSPNAK ECCCCCHHHCCCCCC | 31.84 | 26657352 | |
| 254 | Phosphorylation | PAPQSQLSPNAKEFV CCCHHHCCCCCCHHC | 14.42 | 21082442 | |
| 317 | Phosphorylation | NSLFLEKTPFVEGLS CCEEECCCCCCCEEC | 16.75 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TOB2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TOB2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CNOT7_HUMAN | CNOT7 | physical | 10602502 | |
| PABP1_HUMAN | PABPC1 | physical | 17785442 | |
| CAF1A_HUMAN | CHAF1A | physical | 17785442 | |
| PAN2_HUMAN | PAN2 | physical | 17785442 | |
| CNOT7_HUMAN | CNOT7 | physical | 25416956 | |
| CEP76_HUMAN | CEP76 | physical | 25416956 | |
| PABP1_HUMAN | PABPC1 | physical | 23340509 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254, AND MASSSPECTROMETRY. | |